Isaac Ciechanover, new Qiming partner

All in on ear­ly-stage, Qim­ing US bags $260M, re­cruits Atara founder Isaac Ciechanover for Fund III

Even as some of the pub­lic biotech com­pa­nies in its port­fo­lio bend un­der the weight of a bear mar­ket, Qim­ing Ven­ture Part­ners USA is rolling up its sleeves to build more star­tups.

The VC firm has tak­en the wraps off a $260 mil­lion third fund, dubbed US Health­care Fund III, to ex­e­cute on the same strat­e­gy as pre­vi­ous funds: in­vest in ear­ly-stage ther­a­peu­tics and health­care tech­nol­o­gy com­pa­nies in the US and the EU.

Endpoints News

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters